Re-hospitalized Patients With Acute Coronary Syndrome (BoomerangACS)

January 22, 2020 updated by: Mehdi Zoghi, Cardiovascular Academy Society, Turkey

Demographic, Clinical Characteristics and Medications of Re-hospitalized Patients for Acute Coronary Syndrome

The predictors of re-hospitalization of patients with history of acute coronary syndrome

Study Overview

Status

Completed

Conditions

Detailed Description

The aim of this retrospective multicenter study is to evaluate the demographic, clinical characteristics and medications of re-hospitalized for new cardiac event in patients with history of acute coronary syndrome within in 12 months.

Study Type

Observational

Enrollment (Actual)

577

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • İzmir, Turkey
        • Cardiovascular Academy Society

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The aim of this retrospective multicenter study is to evaluate the demographic, clinical characteristics and medications of re-hospitalized for new cardiac event in patients with history of acute coronary syndrome within in 12 months. To the best of our knowledge, this is the first study to evaluate the characteristics of re-hospitalized patients for ACS. The case report forms which attached in excel must be filled by investigators case by case based on recorded data.

Description

Inclusion Criteria:

Patients age >18 years who had hospitalized for acute coronary syndrome within 12 months

Exclusion Criteria:

Patients whose previous hospitalizations data are not available Myocardial Infarction, type 2 patients

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical and demographics characteristics of patients re-admitted with acute coronary syndrome
Time Frame: Up to 1 year
The demographics and clinical characteristics of study population Admissions with an 'I'-group ICD-10 code
Up to 1 year
Cardiovascular Hospitalization
Time Frame: Up to 1 year
Predictive factors for patients re-admitted with acute coronary
Up to 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Cardiovascular Academy Society, Turkey

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 15, 2018

Primary Completion (Actual)

September 15, 2019

Study Completion (Actual)

November 15, 2019

Study Registration Dates

First Submitted

October 30, 2018

First Submitted That Met QC Criteria

October 31, 2018

First Posted (Actual)

November 1, 2018

Study Record Updates

Last Update Posted (Actual)

January 23, 2020

Last Update Submitted That Met QC Criteria

January 22, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2018-2

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Coronary Syndrome

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kuwait

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe